Clinical Trials in Nashville

Showing 16541-16560 of 20,298 trials

A Retrospective Cohort Study of Infusion Reactions Due to Vectibix

NCT01156090

The purpose of this study is to identify approximately 100 - 150 patients who have received Vectibix (Panitumumab) in offices and clinics located in Tennessee, North Carolina, South Carolina, and North Georgia from February 2004 - April 2009. Information regarding the incidence and severity of hypersensitivity infusion reactions to Vectibix (Panitumumab)will be captured. In patients who experienced hypersensitivity reactions, the following information will also be collected: premedication, treatment cycle symptoms that were experienced during chemotherapy, changes required in subsequent Vectibix (Panitumumab) or chemotherapy treatment, and outcome of the hypersensitivity reaction.

Infusion Reaction

SCRI Development Innovations, LLC141 participantsStarted Jun 2010

Jonesboro, Arkansas, United States • Augusta, Georgia, United States • Gainesville, Georgia, United States +4 more locations

TERMINATEDPhase 1< 1 mile

Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer

NCT01281163

This phase I trial studies the side effects and the best dose of lapatinib ditosylate and Akt inhibitor MK2206 in treating women with metastatic breast cancer. Lapatinib ditosylate and Akt inhibitor MK2206 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Positive+4 more

National Cancer Institute (NCI)4 participantsStarted Jan 2011

New Haven, Connecticut, United States • Boston, Massachusetts, United States • Ann Arbor, Michigan, United States +2 more locations

A Retrospective Cohort Study of Infusion Reactions Due to Vectibix

Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer

Find Trials by Condition in Nashville

Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction

Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot

Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa

A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Surgical Reduction of the Inferior Turbinates for Nasal Obstruction

S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Effect of Febuxostat on Blood Pressure

Gadobutrol Enhanced MRA of the Renal Arteries

Safety Study for the Treatment of Abdominal Aortic Aneurysms

Talking Card for Asthma

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.

A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies

Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors